Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD
Prospective evaluation of the carbon footprint and clinical utility of IBUS compared with colonoscopy and enterography in ulcerative colitis…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease [Phase 4]
This Phase 4 clinical trial is evaluating combinations of vedolizumab IV with adalimumab or vedolizumab with ustekinumab in adults with Croh…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
A clinico-biological collection study designed to investigate the pathophysiology of systemic autoimmune diseases, including systemic lupus …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
A 5-year longitudinal observational study is being conducted on patients receiving therapy for inflammatory bowel disease. The trial is spon…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Zymfentra (Infliximab-dyyb) REal World Cohort STudy
A real-world cohort study of Zymfentra (Infliximab-dyyb) is being conducted by the University of North Carolina, Chapel Hill to evaluate its…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy [Phase 2]
Phase 2 clinical trial evaluating AZD7798 for treatment in Crohn's disease patients with an ileostomy; recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy [NA]
This clinical trial update notes a recruiting study assessing the safety of mesentery-embedding surgery in patients with ileocolic Crohn's d…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 2]
Phase 2 pediatric trial evaluating the long-term safety of intravenous vedolizumab in children with ulcerative colitis or Crohn's disease; r…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Study of Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease. [NA]
Clinical trial evaluating concordance between inflammatory activity in ileal Crohn's disease as assessed by enteric MRI with and without an …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease [Phase 2, Phase 3]
A clinical trial update indicates Janssen's study of Icotrokinra for moderately to severely active Crohn's disease is in Phase 2/Phase 3 and…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
A clinical trial evaluating PET/MR enterography using a collagen-binding radiotracer to assess Crohn's disease.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease [Phase 2]
Phase 2 clinical trial investigating how the gut microbiota influences host cell energy metabolism in health and in inflammatory bowel disea…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease [Phase 2]
A Phase 2 clinical trial sponsored by Mirador Therapeutics is evaluating therapies for inflammatory bowel disease, including ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease [Phase 3]
Phase 3 trial evaluating PROCHYMAL for treatment-refractory moderate-to-severe Crohn's disease has completed. The sponsor was Mesoblast, and…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease [Phase 3]
An extended Phase 3 evaluation of PROCHYMAL adult human stem cells for treatment-resistant Crohn's disease has completed, according to Mesob…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease [Phase 2, Phase 3]
A Phase 2/3 trial evaluating personalized, model-informed induction dosing of infliximab in Crohn's disease has been terminated with results…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease [Phase 3]
A Phase 3 trial evaluating PROCHYMAL (allogeneic mesenchymal stem cells) for treatment-resistant moderate-to-severe Crohn's disease has comp…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Response Assessment in SB CD
This entry notes a clinical trial update for a study on response assessment in Crohn's disease affecting the small intestine, sponsored by W…
-
FDA approval · 2026-03-06FDA Approved: SKYRIZI — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for SKYRIZI (risankizumab-rzaa) from AbbVie Inc. The action updates or expands the drug's regulatory…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease [NA]
This clinical trial update describes the development of a self-management intervention intended to improve health outcomes for patients with…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial [Phase 4]
Phase 4 OPTIMIZE trial investigates proactive dosing optimization of infliximab in inflammatory bowel disease using a pharmacokinetic dashbo…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Effect of Grapes in Inflammatory Bowel Disease [NA]
A completed clinical trial investigated the effect of grapes as a dietary intervention for inflammatory bowel disease, focusing on Crohn's d…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Qualitative Exploration of Key Symptoms of Stricturing Crohn's Disease: Toward the Development of a Clinical Assessment Score.
This clinical trial update describes a qualitative study of key symptoms in stricturing Crohn's disease to develop a clinical assessment sco…
-
EMA approval · 2026-03-03EMA Authorised: Entyvio (vedolizumab) — Takeda Pharma A/S
The European Medicines Agency authorised Entyvio (vedolizumab) for the treatment of ulcerative colitis and Crohn's disease, with Takeda Phar…